Executive Vice President
HMP Market Access
Lee Blansett has been an active participant in the US healthcare system for more than 20 years. His research into health system organizations and oncology market access topics includes extensive on-the-ground studies in the US and EU. Lee’s previous work includes internal consulting roles with APM, Kaiser Permanente, Stanford Children’s Hospital, and a community oncology group. His work on manufacturers’ behalf includes serving as a Senior Vice President at DaVinci Oncology/Kantar and as a Senior Principal with the IMS Consulting Group. His academic training includes an MBA from the Wharton School and a BSC in finance from Santa Clara University, where he was a National Merit Scholar.
Session 1: CPC + CBEx: A New Agenda in Oncology
Friday, October 6, 2023
9:30 AM – 10:05 AM ET
Critical Trends in the Oncology Landscape
Friday, October 6, 2023
9:30 AM – 9:40 AM ET
Clinical Pathways + Clinical Business Exchange Roadmap: How the Trends Translate to the Real World
Friday, October 6, 2023
9:40 AM – 10:05 AM ET